New antibody conjugate drug improves survival in older patients with acute myeloid leukaemia
(Medical Xpress)—Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to ...
Cancer
Nov 12, 2012 |
not rated yet |
0
How infection can trigger autoimmune disease
Australian scientists have confirmed a 'weak link' in the immune system – identifying the exact conditions under which an infection can trigger an autoantibody response, a process not clearly understood until now.
Immunology
Nov 09, 2012 |
5 / 5 (1) |
1
|
People with natural immunity to HIV may serve as basis for new vaccine
(Medical Xpress)—Despite urgent need and tremendous scientific effort, researchers have yet to discover a vaccine for HIV that adequately protects humans from infection. But some people don't need one. For reasons not completely ...
HIV & AIDS
Nov 09, 2012 |
5 / 5 (1) |
0
Socioeconomic status linked to childhood peanut allergy
Peanut allergies are rising among American children and one reason might be due to economic status. According to a new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting, ...
Immunology
Nov 09, 2012 |
not rated yet |
1
New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory ...
Cancer
Nov 07, 2012 |
not rated yet |
0
Potent antibodies neutralize HIV and could offer new therapy, study finds
(Medical Xpress)—Having HIV/AIDS is no longer a death sentence, but it's still a lifelong illness that requires an expensive daily cocktail of drugs—and it means tolerating those drugs' side effects and ...
Immunology
Nov 07, 2012 |
5 / 5 (2) |
0
|
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Cancer
Nov 06, 2012 |
5 / 5 (2) |
0
Three-in-one 'supermolecule' could detect cancer early, help destroy tumours and monitor treatment
The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study ...
Cancer
Nov 06, 2012 |
not rated yet |
0
New drug may help those who can't take statins
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Cardiology
Nov 05, 2012 |
4 / 5 (3) |
0
|
First gene therapy to go on sale in Europe in 2013
Dutch biotech company uniQure said Monday it would start selling the first human gene therapy to be approved in the West by mid-2013 and predicted an explosion of similar therapies to come.
Genetics
Nov 05, 2012 |
not rated yet |
0
Researchers investigate the amyloid-beta peptide behind Alzheimer's
Using solid-state nuclear magnetic resonance (NMR) spectroscopy, researchers at Luleå University of Technology in collaboration with Warwick University in the UK for the first time in the world managed to ...
Alzheimer's disease & dementia
Nov 05, 2012 |
not rated yet |
0
Greater drop in LDL seen with atorvastatin plus PCSK9 antibody
(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) ...
Medical research
Nov 02, 2012 |
5 / 5 (1) |
0
Scientists identify new target for lung cancer treatment
A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed ...
Cancer
Nov 01, 2012 |
4 / 5 (1) |
0
|
Meth vaccine shows promising results in early tests
Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from ...
Psychology & Psychiatry
Nov 01, 2012 |
3 / 5 (2) |
1
|
Novel drug may stop eye disease
(Medical Xpress)—A new drug developed by researchers from Flinders University, in partnership with collaborators in Melbourne, could hold the key to better treatment of some blinding eye diseases.
Ophthalmology
Nov 01, 2012 |
not rated yet |
0
